相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis
U. Rohde et al.
DIABETES OBESITY & METABOLISM (2016)
Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats
Chao Wu Xiao et al.
GENES AND NUTRITION (2014)
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Un Ju Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Hypertension and overweight/obesity in Ghanaians and Nigerians living in West Africa and industrialized countries: a systematic review
Yvonne Commodore-Mensah et al.
JOURNAL OF HYPERTENSION (2014)
A Central Role for mTOR in Lipid Homeostasis
Dudley W. Lamming et al.
CELL METABOLISM (2013)
Hypoxia-Inducible Factor and Vascular Endothelial Growth Factor Are Targets of Dietary Soy During Acute Stroke in Female Rats
Yulin Ma et al.
ENDOCRINOLOGY (2013)
Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts
Jin-Ran Chen et al.
FASEB JOURNAL (2013)
Soy isoflavones modulate adipokines and myokines to regulate lipid metabolism in adipose tissue, skeletal muscle and liver of male Huanjiang mini-pigs
Huansheng Yang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America
Laura R. Aballay et al.
NUTRITION REVIEWS (2013)
Diet beverages and the risk of obesity, diabetes, and cardiovascular disease: a review of the evidence
Mark A. Pereira
NUTRITION REVIEWS (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver
KyeongJin Kim et al.
HEPATOLOGY (2012)
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Timothy R. Peterson et al.
CELL (2011)
Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1c
Min Wan et al.
CELL METABOLISM (2011)
Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
Partha Chakrabarti et al.
DIABETES (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
Shomit Sengupta et al.
NATURE (2010)
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Shijie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
A review - Obesity and screening for breast, cervical, and colorectal cancer in women
Sarah S. Cohen et al.
CANCER (2008)
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Thomas Porstmann et al.
CELL METABOLISM (2008)
Obesity-Associated Liver Disease
Giulio Marchesini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells
Weihua Yu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes
Nicholas F. Brown et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
W. Sterry et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A combination of caffeine, arginine, soy lsoflavones, and L-carnitine enhances both upolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo
Shinji Murosaki et al.
JOURNAL OF NUTRITION (2007)
Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials
Kyoko Taku et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat
Jeremy Davis et al.
ANNALS OF NUTRITION AND METABOLISM (2007)
Dietary isoflavone supplementation modulates lipid metabolism via PPARα-dependent and -independent mechanisms
Orsolya Mezei et al.
PHYSIOLOGICAL GENOMICS (2006)
Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity
S Kim et al.
JOURNAL OF NUTRITION (2005)
Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats
C Ascencio et al.
JOURNAL OF NUTRITION (2004)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis
JE Kim et al.
DIABETES (2004)
Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα
S Kim et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein
ZC Dang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Soy isoflavones: A safety review
IC Munro et al.
NUTRITION REVIEWS (2003)
The immuno suppress ant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation
T Peng et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
分享论文
